Page last updated: 2024-12-06

schizandrin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

schizandrin A: the major lignan, 2-9%, of Schisandra plant; has hepatoprotective, antioxidant, and antineoplastic activities [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID155256
CHEMBL ID253908
SCHEMBL ID2404905
MeSH IDM0106850

Synonyms (48)

Synonym
(-)-dimethylgomisin j
(-)-deoxyschisandrin
(9s,10r)-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0^{2,7}]hexadeca-1(16),2,4,6,12,14-hexaene
gtpl2769
schizandrin a
dibenzo(a,c)cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, stereoisomer
dibenzo(a,c)cyclooctene, 5,6,7,8-tetrahydro-6,7-dimethyl-1,2,3,10,11,12-hexamethoxy-
(+)-deoxyschizandrin
smr000445690
MLS000728483
AC-11192
CHEMBL253908
schisandrin a
61281-38-7
dibenzo(a,c)cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6r,7s,12as)-
69176-53-0
(-)-deoxyschizandrin
di-o-methylgomisin j
HMS2227F15
S3822
AKOS015960456
74xql5do3s ,
unii-74xql5do3s
CS-3658
DTXSID10219222
SCHEMBL2404905
AC-34831
wuweizisu a
schisandrin a (deoxyschisandrin) (constituent of northern schisandra) [dsc]
dibenzo(a,c)cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6r,7s,12ar)-
schizandrin a [who-dd]
HY-N0693
schisandrin a, analytical standard
schisandrin-a
SR-01000777559-3
sr-01000777559
bdbm50485611
schisandrin a, >=98% (hplc)
mfcd09026934
ncgc00385070-01!
(6r,7s)-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c][8]annulene
BS-17208
(6r,7s,12ar)-5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyldibenzo[a,c]cyclooctene
Q15410931
A14531
CCG-268845
C3501
schisandrin a (deoxyschisandrin) (constituent of northern schisandra)

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The method was proved to be rapid, sensitive and reproducible, and it was successfully applied to the pharmacokinetic studies of six lignans in rat plasma after oral administration of Schisandra chinensis extracts."( Rapid determination and pharmacokinetics study of lignans in rat plasma after oral administration of Schisandra chinensis extract and pure deoxyschisandrin.
Chai, Y; Lv, L; Mao, S; Zhang, G; Zhang, H; Zhao, L; Zhu, Z, 2011
)
0.37
" In this work, plasma pharmacokinetic characteristics of lignans components after oral administration SMS were investigated using UPLC-Q-TOF/MS method."( Pharmacokinetic study of schisandrin, schisandrol B, schisantherin A, deoxyschisandrin, and schisandrin B in rat plasma after oral administration of Shengmaisan formula by UPLC-MS.
Han, Y; Sun, H; Wang, X; Wei, W; Wu, F; Zhang, A, 2013
)
0.39
" The parameters area under the plasma concentration-time curve from time zero to the final measurable point and from time zero to infinity, and peak concentration were significantly increased, with a prolonged mean residence time and a corresponding decrease in clearance in comparision with the Schisandra-alone group."( Comparative pharmacokinetics and tissue distribution of schisandrin, deoxyschisandrin and schisandrin B in rats after combining acupuncture and herb medicine (schisandra chinensis).
Dai, G; Ji, D; Li, L; Lu, T; Mao, C; Sun, Y; Wu, X; Xu, B; Yin, F; Zhou, Y, 2014
)
0.4
" After oral administration of FZHY at a dose of 15g/kg, the pharmacokinetic behaviors of schizandrin A (SIA), schizandrin B (SIB), schizandrin C (SIC), schisandrol A (SOA), Schisandrol B (SOB) and schisantherin A (STA) have been significantly changed in hepatic fibrosis rats compared with the normal rats, and their AUC(0-t) values were increased by 235."( Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Liu, CH; Liu, S; Tao, YY; Yang, T; Zheng, TH, 2015
)
0.42
" In pharmacokinetic studies, rats were divided into four groups."( Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Liu, X; Liu, Y; Wang, Y; Zhang, D; Zhang, W, 2018
)
0.48
" We aimed to predict the contribution of schisantherin A and schisandrin A to drug-drug interaction (DDI) between Wuzhi capsule and tacrolimus using physiologically-based pharmacokinetic (PBPK) modelling."( Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling.
Bu, F; Cai, W; Jiao, Z; Li, L; Lin, HS; Ma, G; Shin, JG; Xiang, X; Zhang, H; Zhuang, X, 2018
)
0.48
"9 g/kg SY, nifedipine clearance decreased by 34% and half-life increased by 142%."( Shenmai-Yin decreased the clearance of nifedipine in rats: The involvement of time-dependent inhibition of nifedipine oxidation.
Chen, AC; Chen, WC; Lu, CK; Ueng, YF; Wang, HJ, 2019
)
0.51
" The essential adjusted physicochemical data and pharmacokinetic parameters of SIA, STA, and CsA were collected."( The Pharmacokinetic Prediction of Cyclosporin A after Coadministration with Wuzhi Capsule.
Chen, L; Fan, J; Li, M; Lu, X; Zhu, L, 2019
)
0.51
" This review is the first to provide an overview of SA-related pharmacological effects and pharmacokinetic characteristics."( A review: Pharmacology and pharmacokinetics of Schisandrin A.
Fu, K; Gong, L; Li, Y; Ma, C; Wang, C; Zhang, Y; Zhou, H, 2022
)
0.72

Compound-Compound Interactions

ExcerptReferenceRelevance
" After dynamic catalytic transformation by 201×7 resin combined with purification of HPD5000 resin, the yield and the purity of free biphenyl cyclooctene lignans in the product were 132."( Preparation of high purity biphenyl cyclooctene lignans from Schisandra extract by ion exchange resin catalytic transformation combined with macroporous resin separation.
Liu, TT; Ma, CH; Yang, FJ; Yang, L; Zhang, L; Zhang, ZH; Zhao, CJ; Zu, YG, 2011
)
0.37
" Each group was orally treated with DSD alone (Group 1), DSD combined with EGCG (Group 2), SD alone (Group 3) and SD combined with EGCG (Group 4)."( Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Liu, X; Liu, Y; Wang, Y; Zhang, D; Zhang, W, 2018
)
0.48
" We aimed to predict the contribution of schisantherin A and schisandrin A to drug-drug interaction (DDI) between Wuzhi capsule and tacrolimus using physiologically-based pharmacokinetic (PBPK) modelling."( Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling.
Bu, F; Cai, W; Jiao, Z; Li, L; Lin, HS; Ma, G; Shin, JG; Xiang, X; Zhang, H; Zhuang, X, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" Some ingredients in the extract may increase the dissolution of deoxyschisandrin, delay its elimination and enhance its bioavailability in rat."( Rapid determination and pharmacokinetics study of lignans in rat plasma after oral administration of Schisandra chinensis extract and pure deoxyschisandrin.
Chai, Y; Lv, L; Mao, S; Zhang, G; Zhang, H; Zhao, L; Zhu, Z, 2011
)
0.37
" The appropriate size of nanoparticles (~93 nm), the solubilization of the surfactant, the noncrystalline state of the drug in the matrix and the fast dissolution rate contributed to a significantly enhanced oral bioavailability from the nanoparticles when compared to pure drug suspension."( Schisandra lignans-loaded enteric nanoparticles: preparation, characterization, and in vitro-in vivo evaluation.
Han, J; Huang, Y; Jin, S; Li, X; Lv, Q; Pei, J; Yuan, H, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
" Pretreating mice with Sch A at a daily oral dose of 1 mmol/kg for 3 days did not protect against CCl4 hepatotoxicity, whereas pretreatment with Sch B or Sch C at the same dosage regimen produced almost complete protection."( Methylenedioxy group as determinant of schisandrin in enhancing hepatic mitochondrial glutathione in carbon tetrachloride-intoxicated mice.
Che, CT; Ip, SP; Ko, KM; Ma, CY, 1997
)
0.3
"2 mmol/kg for 3 days did not protect the isolated-perfused hearts against IR-induced damage, pretreatment with Sch B or Sch C at the same dosage regimen produced cardioprotective action."( Methylenedioxy group and cyclooctadiene ring as structural determinants of schisandrin in protecting against myocardial ischemia-reperfusion injury in rats.
Ko, KM; Yim, TK, 1999
)
0.3
" Six lignans pretreatment before APAP dosing could prevent the depletions of total liver glutathione (GSH) and mitochondrial GSH caused by APAP."( Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation.
Bi, H; Chen, P; Fan, X; Huang, M; Jiang, Y; Tan, H; Wang, Y; Zeng, H, 2015
)
0.42
"7 cells in a manner that is dependent on the dosage administered."( Schisandrin A ameliorates airway inflammation in model of asthma by attenuating Th2 response.
Deng, L; He, J; Huang, F; Lin, Q; Liu, K; Luo, L; Qiu, Q; Su, J; Zhang, W, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency25.11890.044717.8581100.0000AID485341
glp-1 receptor, partialHomo sapiens (human)Potency28.18380.01846.806014.1254AID624417
TDP1 proteinHomo sapiens (human)Potency29.09290.000811.382244.6684AID686978; AID686979
67.9K proteinVaccinia virusPotency11.22020.00018.4406100.0000AID720579
serine-protein kinase ATM isoform aHomo sapiens (human)Potency19.95260.707925.111941.2351AID485349
gemininHomo sapiens (human)Potency25.92900.004611.374133.4983AID624296; AID624297
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency79.43283.981146.7448112.2020AID720708
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (64)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID447665Antiviral activity against Hepatitis B virus infected human HepG2.2.15 cells assessed as HBeAg secretion at 25 ug/kg after 9 days by ELISA2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana.
AID313795Antiproliferative activity against human SK-HEP1 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID1371180Substrate activity at CYP3A5 (unknown origin) assessed as enzyme-mediated compound turnover assessed per pmol protein at 10 uM2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1418398Inhibition of P-gp in human KBv200 cells assessed as potentiation of vincristine-induced cytotoxicity by measuring reduction in vincristine IC50 at 25 uM after 96 hrs by Western blot analysis relative to vincristine alone2018European journal of medicinal chemistry, Nov-05, Volume: 159Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance.
AID447658Antiviral activity against Hepatitis B virus infected human HepG2.2.15 cells assessed as HBsAg secretion at 200 ug/kg after 9 days by ELISA2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana.
AID313797Antiproliferative activity against human T47D cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID380426Cytotoxicity against pig LLC-PK1 cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID447664Antiviral activity against Hepatitis B virus infected human HepG2.2.15 cells assessed as HBeAg secretion at 50 ug/kg after 9 days by ELISA2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana.
AID1168388Potentiation of 0.02 uM doxorubicin-induced cytotoxicity in human HL60/MDR cells assessed as viable cells at 25 uM after 48 hrs by WST assay relative to control2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID1168406Potentiation of doxorubicin-induced cell cycle arrest in human HL60/MDR cells assessed as accumulation at S phase at 25 uM after 48 hrs by flow cytometry (Rvb = 59.0 %)2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID447659Antiviral activity against Hepatitis B virus infected human HepG2.2.15 cells assessed as HBsAg secretion at 100 ug/kg after 9 days by ELISA2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana.
AID1168389Potentiation of 0.2 uM doxorubicin-induced cytotoxicity in human HL60/MDR cells assessed as viable cells at 25 uM after 48 hrs by WST assay relative to control2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID380432Inhibition of COX2 in mouse macrophages2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1168390Potentiation of 0.6 uM doxorubicin-induced cytotoxicity in human HL60/MDR cells assessed as viable cells at 25 uM after 48 hrs by WST assay relative to control2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID1168402Cell cycle arrest in human HL60/MDR cells assessed as accumulation at G2/M phase at 25 uM after 48 hrs by flow cytometry (Rvb = 11.3 %)2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID678829TP_TRANSPORTER: inhibition of VP-16 transport in HL60/ADR cells (overexpression of MRP1)2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID678831TP_TRANSPORTER: inhibition of VCR transport in HL60/ADR cells (overexpression of MRP1)2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID447661Antiviral activity against Hepatitis B virus infected human HepG2.2.15 cells assessed as HBsAg secretion at 50 ug/kg after 9 days by ELISA2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana.
AID380428Cytotoxicity against human KB cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID380429Cytotoxicity against human BT549 cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID380431Antiinflammatory activity against LPS-induced prostaglandin E2 production in mouse macrophages upto 25 ug/ml2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID678828TP_TRANSPORTER: inhibition of VP-16 transport in HL60/MRP cells2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID1168391Cytotoxicity against human HL60/MDR cells assessed as viable cells at 25 uM after 48 hrs by WST assay2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID678830TP_TRANSPORTER: inhibition of VCR transport in HL60/MRP cells2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID1168405Potentiation of doxorubicin-induced cell cycle arrest in human HL60/MDR cells assessed as accumulation at G2/M phase at 25 uM after 48 hrs by flow cytometry (Rvb = 59.0 %)2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID1168387Inhibition of P-gp-mediated doxorubicin efflux in human HL60/MDR cells assessed as intracellular doxorubicin accumulation at 25 uM preincubated for 15 mins measured after 60 mins by flow cytometry2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID313800Antiproliferative activity against human A549 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID313796Antiproliferative activity against human SNU638 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID380430Cytotoxicity against human SKOV3 cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1168403Cell cycle arrest in human HL60/MDR cells assessed as accumulation at S phase at 25 uM after 48 hrs by flow cytometry (Rvb = 29.9 %)2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID447660Antiviral activity against Hepatitis B virus infected human HepG2.2.15 cells assessed as HBsAg secretion at 25 ug/kg after 9 days by ELISA2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana.
AID313794Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID313798Antiproliferative activity against human HCT15 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID313799Antiproliferative activity against human K562 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID447663Antiviral activity against Hepatitis B virus infected human HepG2.2.15 cells assessed as HBeAg secretion at 200 ug/kg after 9 days by ELISA2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1371179Substrate activity at CYP3A4 (unknown origin) assessed as enzyme-mediated compound turnover assessed per pmol protein at 10 uM2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5.
AID447662Antiviral activity against Hepatitis B virus infected human HepG2.2.15 cells assessed as HBeAg secretion at 100 ug/kg after 9 days by ELISA2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana.
AID380427Cytotoxicity against human SK-MEL cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1168404Potentiation of doxorubicin-induced cell cycle arrest in human HL60/MDR cells assessed as accumulation at G1 phase at 25 uM after 48 hrs by flow cytometry (Rvb = 59.0 %)2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID380423Antioxidant activity in human HL60 cells assessed as inhibition of TPA-stimulated hydrogen peroxide induced DCFH-DA oxidation by fluorometric microplate assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID682028TP_TRANSPORTER: inhibition of DNR transport in HL60/ADR cells (overexpression of MRP1)2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID1599368Antiviral activity against DENV2 ICC265 infected in human Huh7 cells assessed as reduction in viral titer by plaque assay2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID678832TP_TRANSPORTER: inhibition of DNR transport in HL60/MRP cells2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID1168401Cell cycle arrest in human HL60/MDR cells assessed as accumulation at G1 phase at 25 uM after 48 hrs by flow cytometry (Rvb = 59.0 %)2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID380424Cytotoxicity against human HL60 cells by XTT assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1317165Activation of recombinant human SIRT1 using TPE-GK(Ac)YDD as substrate at 50 uM by fluorescence assay relative to control2016European journal of medicinal chemistry, Aug-25, Volume: 119How much successful are the medicinal chemists in modulation of SIRT1: A critical review.
AID380425Cytotoxicity against african green monkey Vero cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1346741Human Pregnane X receptor (1I. Vitamin D receptor-like receptors)2006The Journal of pharmacology and experimental therapeutics, Mar, Volume: 316, Issue:3
Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats.
AID1346802Mouse Pregnane X receptor (1I. Vitamin D receptor-like receptors)2006The Journal of pharmacology and experimental therapeutics, Mar, Volume: 316, Issue:3
Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (150)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.33)18.7374
1990's4 (2.67)18.2507
2000's22 (14.67)29.6817
2010's93 (62.00)24.3611
2020's29 (19.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.66%)5.53%
Reviews5 (3.31%)6.00%
Case Studies1 (0.66%)4.05%
Observational0 (0.00%)0.25%
Other144 (95.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]